<< European countries to review impact of environmental policies on popluation health status | FDA approves Abbott's TECNIS Multifocal 1-Piece intraocular lens for cataract patients >>

Cempra Pharmaceuticals completes Phase 1 clinical trials of CEM-101 macrolide

Published on March 10, 2010 at 7:37 AM · No Comments

Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1 study with the company's intravenous formulation of CEM-101 in mid-2010.

CEM-101 is a next-generation macrolide with potent activity against pneumococci, including macrolide- and quinolone-resistant strains. Bacterial pneumonia caused by multi-drug resistant pneumococci can result in clinical treatment failure and subsequent increases in healthcare costs.

Continued on Next page >>

Azithromycin shows promise against trachoma-related blindnessA UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective...
Financial Times examines product development partnerships developing drugs for neglected diseasesThe Financial Times examines the rise of product development partnerships (PDPs), which are "non-gov...
GBS pathogen suppresses immune cell function in newborn infants: ResearchGroup B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infan...
Wellington Foods moves to new cGMP compliant manufacturing facilityWellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion o...
pSivida reports interim results of human PK study of IluvienpSivida Corp, a leading drug delivery company that has developed two of the only three products appr...
Farmer receives U.N. appointment; Fight against Malaria in Africa"Former U.S. president Bill Clinton, who is now the U.N. special envoy to Haiti, announced the appoi...
Human cytomegalovirus may help doctors treat glioblastoma multiformeA common human virus may prove useful in attacking the deadliest form of brain tumors, according to ...
Survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapyMany of the more than 5 million HIV-infected people living in India have been unable to obtain treat...
Researchers have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' diseaseResearchers at Columbia University Medical Center have decoded the genome of Legionella pneumophila,...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.